HIV-1 T-cell vaccines: evaluating the next step.


Autoria(s): Pantaleo G.
Data(s)

2008

Identificador

http://serval.unil.ch/?id=serval:BIB_F91BBFE5C31F

isbn:1473-3099

pmid:18060842

doi:10.1016/S1473-3099(07)70266-9

isiid:000252675300002

Idioma(s)

en

Fonte

Lancet Infectious Diseases, vol. 8, no. 2, pp. 82-83

Palavras-Chave #AIDS Vaccines; Adenoviridae; Antibodies, Viral; Clinical Trials, Phase II as Topic; Genetic Vectors; HIV Infections; HIV-1; Human Immunodeficiency Virus Proteins; Humans; T-Lymphocytes; Treatment Failure; Viral Load
Tipo

info:eu-repo/semantics/article

article